Cart
sales@molnova.com
Bromodeoxyuridine (BrdU)
CAS No. 59-14-3
Bromodeoxyuridine (BrdU)( BrdU | Bromodeoxyuridine | Broxuridine | NSC 38297 )
Catalog No. M15191 CAS No. 59-14-3
Bromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 32 | In Stock |
|
| 500MG | 48 | In Stock |
|
| 1G | 79 | In Stock |
|
Biological Information
-
Product NameBromodeoxyuridine (BrdU)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.
-
DescriptionBromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.
-
In Vitro——
-
In Vivo——
-
SynonymsBrdU | Bromodeoxyuridine | Broxuridine | NSC 38297
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number59-14-3
-
Formula Weight307.1
-
Molecular FormulaC9H11BrN2O5
-
Purity>98% (HPLC)
-
SolubilityEthanol: 3 mg/mL warmed (9.76 mM); DMSO: 61 mg/mL (198.63 mM); Water: <1 mg/mL
-
SMILESOC[C@@H]1[C@H](C[C@H](N2C(NC(C(Br)=C2)=O)=O)O1)O
-
Chemical Name5-Bromo-2'-deoxyuridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Levkoff LH, et al. Neoplasia. 2008, 10(8), 804-816.
molnova catalog
related products
-
Memantine
Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors.
-
AGX51
AGX51 is an antagonist of inhibitor of DNA binding (ID) proteins. AGX51 treatment lead to pan-Id degradation, cell cycle arrest, and cell death.
-
ProINDY
ProINDY (Pro-indy) is a potent DYRK inhibitor that activates NFAT for the study of Down syndrome.
